AXDX Insider Trading
Insider Ownership Percentage: 43.60%
Insider Buying (Last 12 Months): $314,000.00
Insider Selling (Last 12 Months): $23,203.09
Accelerate Diagnostics Insider Trading History Chart
This chart shows the insider buying and selling history at Accelerate Diagnostics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Accelerate Diagnostics Share Price & Price History
Current Price: $0.13
Price Change: ▼ Price Decrease of -0.018 (-12.16%)
As of 05/12/2025 05:00 PM ET
Accelerate Diagnostics Insider Trading History
Accelerate Diagnostics Institutional Trading History
Data available starting January 2016
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Read More on Accelerate Diagnostics
Volume
14,984,275 shs
Average Volume
169,525 shs
Market Capitalization
$3.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.22
Who are the company insiders with the largest holdings of Accelerate Diagnostics?
Who are the major institutional investors of Accelerate Diagnostics?
Which institutional investors are selling Accelerate Diagnostics stock?
During the previous quarter, AXDX stock was sold by these institutional investors:
- Griffin Asset Management Inc.
During the last year, company insiders that have sold Accelerate Diagnostics company stock include:
- John Patience (Director)
- Jack Phillips (CEO)
- Larry Michael Mertz (CTO)
Learn More investors selling Accelerate Diagnostics stock.
Which institutional investors are buying Accelerate Diagnostics stock?
Within the previous quarter, AXDX stock was purchased by institutional investors including:
- Simplex Trading LLC